<DOC>
	<DOCNO>NCT01091935</DOCNO>
	<brief_summary>The purpose study prospectively determine side effect profile adult neuropathic pain receive intravenous infusion lidocaine 5 mg per kg lean body weight , infuse 45 minute .</brief_summary>
	<brief_title>Safety Intravenous Lidocaine Infusions</brief_title>
	<detailed_description>Eligibility Criteria : Adults &gt; 18 yr chronic central peripheral neuropathic pain St Joseph 's Health Care Pain Clinic June December 2009 . Outcome measure : All side effect spontaneously report . Sedation , nausea , dizziness Visual Analog Score Q 15 minute ; hemodynamic data q 5 minute infusion 30 minute . Daily diary side effect Visual Analogue score Pain 7 day post-infusion .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Adult outpatient &gt; 18 year &lt; 80 year diagnose chronic neuropathic pain Unable provide inform consent Unable speak understand English Liver , kidney , cardiac failure Allergy Lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Lidocaine , Intravenous Infusions , Neuropathic Pain , Side Effects</keyword>
</DOC>